Adenosine Diphosphate

dual specificity phosphatase 2 ; Homo sapiens







30 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33047470 Sulfenylome analysis of pathogen-inactivated platelets reveals the presence of cysteine oxidation in integrin signaling pathway and cytoskeleton regulation. 2021 Jan 1
2 31931718 Salvianolic acid a inhibits platelet activation and aggregation in patients with type 2 diabetes mellitus. 2020 Jan 13 1
3 32356316 Novel factor Xa inhibitor, maslinic acid, with antiplatelet aggregation activity. 2020 Dec 1
4 30204045 Comparison of platelet function tests for the in vitro quality assessment of platelet concentrates produced under real-life conditions. 2019 3
5 30916503 [PLATELETS FUNCTION IN A DROP OF BLOOD: FLOW CYTOMETRY ANALYSIS COMPARED TO PLATELET AGGREGATION]. 2019 Mar 1
6 30343298 A Proposed Role of Surfactant in Platelet Function and Treatment of Pulmonary Hemorrhage in Preterm and Term Infants. 2018 1
7 28190975 Reduced platelet hyper-reactivity and platelet-leukocyte aggregation after periodontal therapy. 2017 1
8 28300459 Mildly elevated unconjugated bilirubin is associated with reduced platelet activation-related thrombogenesis and inflammation in Gilbert's syndrome. 2017 Dec 1
9 25734213 DL-3-n-butylphthalide inhibits platelet activation via inhibition of cPLA2-mediated TXA2 synthesis and phosphodiesterase. 2015 1
10 26662400 Platelet parameters and expression of platelet membrane glycoprotein in childhood acute lymphoblastic leukemia. 2015 Dec 7 1
11 25077998 Salvianolic acid B inhibits platelets as a P2Y12 antagonist and PDE inhibitor: evidence from clinic to laboratory. 2014 Oct 1
12 20946295 Comparison of two platelet activation markers using flow cytometry after in vitro shear stress exposure of whole human blood. 2011 Feb 1
13 21565849 Platelet reactivity and endothelial function in children of patients with early acute myocardial infarction. 2011 Aug 1
14 18217151 Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement. 2008 Jan 2
15 16308186 The Retention Index Test Homburg (RTH-II): Response to clopidogrel and comparison with aggregometry and CD62P-expression. 2006 Feb 1
16 16551937 The effects of test temperature and storage temperature on platelet aggregation: a whole blood in vitro study. 2006 Apr 1
17 15786005 Hypothermia-induced platelet aggregation: no effect of aprotinin (trasylol) but inhibition by eptifibatide (integrilin). 2005 Apr 1
18 15960075 Effects of hemoglobin vesicles on resting and agonist-stimulated human platelets in vitro. 2005 1
19 14693172 Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y12 antagonist AR-C 69331 MX on CD62p expression and formation of platelet-leukocyte aggregates. 2003 1
20 24616605 Platelet activity and sensitivity to agonists after exhaustive treadmill exercise. 2003 Mar 1
21 11841696 Megakaryothrombopoiesis during ex vivo expansion of human cord blood CD34+ cells using thrombopoietin. 2002 Jan 2
22 11858493 Paradoxical platelet activation was not observed on dissociation of abciximab from GpIIb-IIIa complexes. 2002 Feb 1
23 11904526 Effects of combined therapy with clopidogrel and acetylsalicylic acid on platelet glycoprotein expression and aggregation. 2002 Apr 2
24 12413588 Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate. 2002 Jul 15 1
25 11560568 Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers. 2001 Sep 1
26 10030830 Cilostazol inhibits the expression of activation-dependent membrane surface glycoprotein on the surface of platelets stimulated in vitro. 1999 Feb 1 1
27 10375966 [Detection of activated platelets by flow cytometry]. 1999 May 3
28 10411706 Fibrinogen fragments and platelet dysfunction in uremia. 1999 Jul 2
29 9001693 Platelet activation in newborns detected by flow-cytometry. 1996 2
30 8325838 Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect. 1993 Jul 15 1